Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia

Marcus Järås(Lund University), Benjamin L. Ebert(Dana-Farber Cancer Institute)
The Journal of Experimental Medicine
March 10, 2014
Cited by 93


Related Papers